# A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs

> **NCT07069569** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Ausper Biopharma Co., Ltd.** · enrollment: 127 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** AHB-137
- **DRUG:** Peg-IFN
- **DRUG:** Hepatitis B Vaccine

## Key facts

- **NCT ID:** NCT07069569
- **Lead sponsor:** Ausper Biopharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-05-30
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-05-01
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2025-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07069569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07069569, "A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07069569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*